With Cencora pact, Gilead looks to grow CAR-T treatment center network.

{
  "signal_id": "efb6199c-2f55-483e-b189-72781a081235",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-06-03T17:04:51+00:00",
  "company": {
    "name": "Cencora",
    "domain": "cencora.com"
  },
  "data": {
    "url": "https://sfbn.org/san-francisco-biotech-news/2026/06/03/with-cencora-pact-gilead-looks-to-grow-car-t-treatment-center-network",
    "title": "With Cencora pact, Gilead looks to grow CAR-T treatment center network.",
    "excerpt": "With Cencora pact, Gilead looks to grow CAR-T treatment center network.\n\nJune 3, 2026 San Francisco Biotechnology Network News News, Syndication Comments Off on With Cencora pact, Gilead looks to grow CAR-T treatment center network\n\nCencora and Gilead have expanded their longstanding partnership, cutting a deal in which the distribution giant will support access to the CAR-T cancer therapies Yescarta and Tecartus.\nClick here to view original post",
    "summary": "Cencora, Inc. partnered with Gilead Sciences on Jun 3rd '26.",
    "category": "partners_with",
    "found_at": "2026-06-03T17:04:51Z",
    "planning": false,
    "image_url": "https://sfbn.org/wp-content/uploads/2026/06/dlthub-named-2026-snowflake-startup-program-product-partner-of-the-year-80x60.jpg",
    "confidence": 0.4944,
    "published_at": "2026-06-03T17:04:51Z",
    "effective_date": "2026-06-03",
    "article_sentence": "Cencora and Gilead have expanded their longstanding partnership, cutting a deal in which the distribution giant will support access to the CAR-T cancer therapies Yescarta and Tecartus."
  }
}

curl https://signals.autobound.ai/v1/signals/efb6199c-2f55-483e-b189-72781a081235 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"cencora.com","limit":20}'